Accendra Health, Inc. Form 8-K Filing Summary

This filing details Accendra Health, Inc.'s early results and settlement of exchange offers for its 4.500% Senior Notes due 2029 and 6.625% Senior Notes due 2030. The company successfully exchanged a substantial portion of these notes for new 9.000% Senior Secured First Lien Notes due 2032 and 9.750% Senior Secured Second Lien Notes due 2033. The early settlement, which occurred on June 15, 2026, resulted in the cancellation of most of the existing notes and the issuance of new notes totaling $213.0 million in First Lien Notes and $698.0 million in Second Lien Notes. Additionally, $326.25 million in First Lien Notes were issued through a new money offering. The company also entered into a Fourth Amendment to its Credit Agreement, establishing a new $300.0 million revolving credit facility and amending covenants. A Second Amendment to the Term Loan Credit Agreement included a waiver of mandatory prepayment provisions and modifications to covenants.